Increased Resource Use in Men With Metastatic Prostate Cancer Does Not Result in Improved Survival or Quality of Care at the End of Life

Cancer - United States
doi 10.1002/cncr.31297
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Spirituality and End-Of-Life Care in Disadvantaged Men Dying of Prostate Cancer

World Journal of Urology
Urology
2010English

Overall Survival and Second Primary Malignancies in Men With Metastatic Prostate Cancer

PLoS ONE
Multidisciplinary
2020English

Living With Treatment Decisions: Regrets and Quality of Life Among Men Treated for Metastatic Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2001English

Pcn248 - Use of Cancer Drugs in the End-Of-Life in Men Dying of Castration-Resistant Prostate Cancer: Population-Based Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Quality of Life Decrements in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2016English

Nine-Year Prostate Cancer Survival Differences Between Aggressive Versus Conservative Therapy in Men With Advanced and Metastatic Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

Predictors of Survival Outcomes in Native Sub Saharan Black Men Newly Diagnosed With Metastatic Prostate Cancer

BMC Urology
MedicineReproductive MedicineUrology
2017English

Circulating Fibroblast-Like Cells in Men With Metastatic Prostate Cancer

Prostate
OncologyUrology
2012English

Does Use of Androgen Deprivation Therapy (ADT) in Men With Prostate Cancer Increase the Risk of Sarcopenia?

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy